Personalised advice : If you are considering whether to pause your injections during Ramadan or you have already missed a dose, our healthcare professionals can provide clear guidance on the safest way to move forward
Protocol 4: Post-menopausal metabolic restoration Goal: Address menopausal weight gain and metabolic changes Stack: Tirzepatide: Standard protocol (addresses insulin resistance) Tesamorelin: 1-2mg daily (visceral fat) CJC-1295/Ipamorelin: 200mcg each before bed (body composition, bone density) Resistance training: 3-4x per week Adequate protein and calcium Duration: 12+ months, potentially ongoing Expected results: 25-45 pounds weight loss Reduced visceral fat Improved insulin sensitivity Better body composition Maintained bone density Why this works: Addresses multiple menopausal factors - insulin resistance, visceral fat, muscle loss, bone density
No evidence of genotoxic activity was found in either assay
The glutathione biosynthesis pathway activity was decreased in the livers of HFD-fed mice
Paulina & Elena Rueda Dama Health | Co-Founders Forefront of advancing women's care Personalized, data-driven protocols 150+ clinical data points assessed Guided Dosing Protocol Your clinician tailors your dose and titration schedule to your individual needs, with adjustments based on your labs and how you respond
In the case of the tirzepatide product that failed sterility testing, a patient received an injectable that the pharmacys own lab determined was not sterile